Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Pharmaids Pharmaceuticals has informed the BSE that its trading window for designated persons and their immediate relatives will be closed from January 1, 2026, until 48 hours after the company declares its unaudited financial results for the quarter and nine months ended December 31, 2025. The closure is being done as per SEBI's Insider Trading Regulations and the company's internal code of conduct. The Board meeting date to consider and approve these Q3 and 9-month FY26 results has not yet been announced and will be communicated later. The communication is signed by the Company Secretary & Compliance Officer, Prasanna Subramanya Bhat.
Directors, key managerial personnel, and their immediate family members cannot buy or sell the company's shares during the closed window. This is a routine compliance step ahead of the upcoming Q3 FY26 results announcement, which could be a near-term catalyst for the stock.